@article{ac2aecd3f38147bb9272b3f83ae1a4d9,
title = "Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis (Protocol)",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of dose reduction or discontinuation of disease-modifying anti-rheumatic drugs in children and young people with clinically inactive juvenile idiopathic arthritis. This is a common protocol for two separate reviews: one on systemic onset juvenile idiopathic arthritis and one on non-systemic juvenile idiopathic arthritis. A secondary objective is to keep the evidence current, using a living systematic review approach.",
author = "Renton, {William D.} and Georgina Tiller and Jane Munro and Joachim Tan and Johnston, {Renea V.} and Avery, {Jodie C.} and Whittle, {Samuel L.} and Anneliese Arno and Rachelle Buchbinder",
note = "Funding Information: Elements of the methods section are based on a template developed by the Cochrane Musculoskeletal Editorial base and Cochrane guidance on living reviews. This Cochrane Review will provide an evidence synthesis to inform one or more recommendations in the Australian National Living Guidelines for Juvenile Idiopathic Arthritis (JIA). These guidelines are being funded by a Commonwealth Department of Health grant – Public Health and Chronic Disease Program Arthritis – Health Professional Education and Training. The funder had no role in the formulation of this question, and will have no role in the preparation of the review. Funding Information: SL Whittle is supported, in part, by an Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trial Network Practitioner Fellowship National Health and Medical Research Council, Australia Funding Information: Elements of the methods section are based on a template developed by the Cochrane Musculoskeletal Editorial base and Cochrane guidance on living reviews. This Cochrane Review will provide an evidence synthesis to inform one or more recommendations in the Australian National Living Guidelines for Juvenile Idiopathic Arthritis (JIA). These guidelines are being funded by a Commonwealth Department of Health grant ? Public Health and Chronic Disease Program Arthritis ? Health Professional Education and Training. The funder had no role in the formulation of this question, and will have no role in the preparation of the review. Funding Information: R Buchbinder is supported by an Australian National Health and Medical Research Council Investigator Fellowship Publisher Copyright: Copyright {\textcopyright} 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",
year = "2022",
month = jan,
day = "11",
doi = "10.1002/14651858.CD014961",
language = "English",
volume = "2022",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley & Sons",
number = "1",
}